首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Triterpenoids as Novel Natural Inhibitors of Human Cathepsin L
Authors:Suelem D Ramalho  Lorena R F De?Sousa  Liliane Nebo  Stella H Maganhi  Ignez Caracelli  Julio Zukerman‐Schpector  Maria Inês S Lima  Marcio F M Alves  M Fátima das G F Da?Silva  João B Fernandes  Paulo C Vieira
Institution:1. Department of Chemistry, Federal University of S?o Carlos, 13565‐905 S?o Carlos, SP, Brazil, (phone: +55‐16‐33518061;2. fax: +55‐16‐33518350);3. BioMat‐Department of Physics, Federal University of S?o Carlos, 13565‐905 S?o Carlos, SP, Brazil;4. Department of Botany, Federal University of S?o Carlos, 13565‐905 S?o Carlos, SP, Brazil;5. Department of Biophysics, Federal University of S?o Paulo, 04039?–?032 S?o Paulo, SP, Brazil
Abstract:Cathepsins L (catL) and B play an important role in tumor progression and have been considered promising therapeutic targets in the development of novel anticancer agents. Using a bioactivity‐guided fractionation, a series of triterpenoids was identified as a new class of competitive inhibitors towards cathepsin L with affinity values in micromolar range. Among the 14 compounds evaluated, the most promising were 3‐epiursolic acid ( 3 ), 3‐(hydroxyimino)oleanolic acid ( 9 ), and 3‐(hydroxyimino)masticadienoic acid ( 13 ) with IC50 values of 6.5, 2.4, and 2.6 μM on catL, respectively. Most of the evaluated triterpenoids do not inhibit cathepsin B. Thus, the evaluated compounds exhibit a great potential to help in the design of new inhibitors with enhanced potency and affinity towards catL. Docking studies were performed in order to gain insight on the binding mode and SAR of these compounds.
Keywords:Triterpenoids  Cathepsin L  Inhibitors
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号